PRIMENENIE PANTOPRAZOLA V SKhEMAKh POSLEDOVATEL'NOY TERAPII HELICOBACTER PYLORI-INFEKTsII


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article presents the results of a comparative study of two schemes of modified consecutive antihelicobacter therapy: the first scheme included the lengthening of the period of treatment up to 14 days - 7 days at each stage, and the second scheme included the drug bismuth (De-Nol) for the all period of therapy (14 days). Pantoprazole (Controloc) was used in these schemes as a proton pump inhibitor. The results showed that consecutive therapy with Controloc and including De-Nol provides the eradication rate of more than 90 %, and can be a good alternative to current eradication schemes of first-line treatment of patients with H. pylori infection.

Texto integral

Acesso é fechado

Bibliografia

  1. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53.
  2. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;28:1960-66.
  3. Saad RJ, Chey WD. Treatment of Helicobacter pylori infection in 2006. Gastroenterol Hepatol Annu Rev 2006;1:30-56.
  4. Malfertheiner P, Megraud F, OMorain C, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht III Consensus Report. Gut 2007;56:772-81.
  5. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection -the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
  6. De Francesco V, MargottaM, Zullo A, et al. Claritromicin resistence and Helicobacter pylori genotypes in Italy. J Microbiol 2006; 44(6):660-64.
  7. Marshall B. Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients. Ann Intern Med 2008;148:962-63.
  8. Caselli M, Zullo A, Maconi G, et al. Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007;39:782-89.
  9. Chey WD, Wong BCY. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007;102:1808-25.
  10. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Annals of Internal Medicine 2007;146(8):556-63.
  11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
  12. Laheij RJ, Rossum LG, Jansen JB, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999;13:857-64.
  13. Зайцева Н.В., Аминова А.И., Щербаков П.Л. и др. Перспективы использования нитрофурановых препаратов в схемах эрадикации Helicobacter pyloriy детей // Фарматека 2008. № 5. С. 86-90.
  14. Zullo A, Rinaldi V, Winn S, et al. A new highly effective shortterm therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-18.
  15. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001;33:676-79.
  16. Phillips RH, Whitehead MW, Lacey S, et al. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Helicobacter 2000;5: 176-82.
  17. Григорьев П.Я., Яковенко А. В., Яковенко Э.П. и др. Пути оптимизации лечения Helicobacter pylori-инфекции сравнительная эффективность тройной и квадротерапии, используемых в качестве схем первой линии. Экспериментальная гастроэнтерология 2004. № 5. С. 31-8.
  18. Graham DY, Osato MS, Hoffman J, et al. Metronidazole containing guadruple therapy for infection with. metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther 2000;14:745-50.
  19. Яковенко А.В., Григорьев П.Я., Яковенко Э.П. и др. Цитопротекторы в терапии заболеваний желудка. Оптимальный подход к выбору препарата // Клиническая и экспериментальная гастроэнтерология 2006. № 2. С. 56-60.
  20. Fitton A, Wiseman L. Pantoprazole: a review of its pharmacological properties and therapeutic use in acidrelated disorders. Drugs 1996;51(3):460-82.
  21. Reill L, Erhardt F, Fischer R, et al. Effect of oral pantoprazole on 24-hour intragastric pH, serum gastrin profile and drug metabolising enzyme activity in man - a placebo-controlled comparison with ranitidine (abstract no.F252). Gut 1993;34(4):63.
  22. Huber R, Hartmann M, Bliesath H, et al. Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther 1996;34(5):185-94.
  23. Tanaka M, Ohkubo T, Otani K, et al. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4-hydroxylation phenotype and genotype. Clin Pharmacol Ther 1997;62(6):619-28.
  24. Григорьев П.Я. Helicobacter pylori: гастрит, дуоденит, (гастродуоденит), язвенная болезнь // Практикующий врач 1999. № 16. С. 2-6.
  25. Парфенов А.И., Ручкина И.Н., Осипов Г.А. Висмута трикалия дицитрат в лечении больных постинфекционным синдромом раздраженного кишечника // РМЖ 2006. Т. 8. № 2. С. 78-81.
  26. Яковенко Э.П., Агафонова Н.А., Похальская О.Ю. и др. Применение висмута трикалия дицитрата (Де-Нола) - перспективное направление в патогенетической терапии синдрома раздраженного кишечника с диареей // Клин. медицина 2008. № 10. С. 47-52.
  27. Canducci F, Armuzzi A, Cremonini F, at al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates // Aliment Pharmacol Ther 2000;14:1625-29.
  28. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects. Am J Gastroenterol 2002;97:2744-49.
  29. Яковенко Э.П., Григорьев П.Я., Яковенко А.В. и др. Влияние пробиотика бифиформ на эффективность лечения инфекции helicobacter pylori // Тер. архив 2006. Т. 78. № 2. С. 21-6.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies